Note7Creole Posted - 15 hours ago

$RWOD Mr. Peter Moriarty Chief Operating Officer of Anew Medical😎 Peter Moriarty has extensive experience in the pharmaceutical industry both in the United States and internationally. He was a co-founder of Shire Pharmaceuticals, an international specialty pharmaceutical company acquired by Takeda Pharmaceuticals ($TAK: NASDAQ). Until its acquisition, Peter was the Executive Chairman of Prismic Pharmaceuticals, a specialty pharmaceutical company he co-founded in 2011, and where he was also the CEO from 2013 to 2018. Prismic was acquired by FSD Pharma ($HUGE: NASDAQ).

Stock_Titan Posted - 2 days ago

$NBIX $TAK Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder https://www.stocktitan.net/news/NBIX/neurocrine-biosciences-reports-positive-phase-2-data-for-nbi-1065845-3tb0f0elruir.html

DonCorleone77 Posted - 3 days ago

$TAK $ALPMY $SMFG Takeda, Astellas Pharma and Sumitomo Mitsui to establish joint venture company Takeda (TAK), Astellas Pharma (ALPMY), and Sumitomo Mitsui (SMFG) announced that the three companies signed a master agreement on April 22 to establish a joint venture company. The new company will be dedicated to the incubation of early drug discovery programs, primarily originating from Japan and toward the creation of innovative therapeutics. In addition to establishing the joint venture company, Takeda and Astellas will provide support to the joint venture company leveraging their expertise gained from global drug discovery research and development, aiming to accelerate open innovation in early-stage drug discovery, and toward the creation of start-up companies for the benefit of society. The joint venture company plans to begin incubation activities by collaboratively working with academia, pharmaceutical companies, and start-up companies across Japan to enable access to potentially transformative early drug discovery programs. The three companies will further discuss the details of the agreement to complete the inception of the joint venture company and commence operations, aiming for a swift launch of the new incubation activities.

DonCorleone77 Posted - 6 days ago

$TAK FDA approves subcutaneous administration of Takeda's ENTYVI in Crohn's disease Takeda "announced that the FDA has approved ENTYVIO subcutaneous administration for maintenance therapy in adults with moderately to severely active Crohn's disease after induction therapy with intravenous ENTYVIO. The subcutaneous administration of ENTYVIO was also approved by FDA in September 2023 for the maintenance treatment of adults with moderately to severely active ulcerative colitis and is available in the U.S. as a single-dose prefilled pen. The approval is based on the VISIBLE 2 Study (SC CD Trial), a Phase 3, randomized, double-blind, placebo-controlled trial, which assessed the safety and efficacy of an SC formulation of ENTYVIO as maintenance therapy in adult patients with moderately to severely active CD who had clinical response** at Week 6 following two doses of open-label vedolizumab intravenous therapy at Weeks 0 and 2.1 The primary endpoint was clinical remission at Week 52, which was defined as a total Crohn's Disease Activity Index score of less than or equal to 150."

Stock_Titan Posted - 1 week ago

$TAK U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease https://www.stocktitan.net/news/TAK/u-s-fda-approves-subcutaneous-administration-of-takeda-s-entyvio-r-nt8srpj9mkct.html

stOck_mane Posted - 1 week ago

$TAK if this ever goes under the $13 mark im in.

Deadman3906 Posted - 2 weeks ago

$TAK $E $A $SEAT

Stock_Titan Posted - 2 weeks ago

$TAK Takeda Announces New U.S. Corporate Social Responsibility Program Partners to Build Equity through STEM Education and Access to Nutritional Food https://www.stocktitan.net/news/TAK/takeda-announces-new-u-s-corporate-social-responsibility-program-jlabooy3cjvl.html

Broview Posted - 2 weeks ago

$TAK Lon term holding

Vestorinvest Posted - 3 weeks ago

$YALA $LYT $TAK Party at CREG! Ppe

tradelessveryless Posted - 03/26/24

$VVOS $OSAP $INSP $RMD $TAK $TSP ….. $vvos could report soon… potentially great ER ! please do your due diligence. Every stock is risky(including $vvos) at any given time.

briefingcom Posted - 03/26/24

$TAK: Takeda Pharma (+1.8%) announces that the Japanese Ministry of Health, Labour and Welfare has approved the use of ADZYNMA for the treatment of congenital thrombotic thrombocytopenic purpura for individuals 12 years of age and older https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240326081010TAK&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Stock_Titan Posted - 03/26/24

$TAK Takeda Announces Approval of ADZYNMA® Intravenous Injection 1500 (apadamtase alfa /cinaxadamtase alfa) in Japan for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP) https://www.stocktitan.net/news/TAK/takeda-announces-approval-of-adzynma-r-intravenous-injection-1500-b8orf85ui51d.html

DMAY0 Posted - 1 month ago

$TAK missed getting into next divi

howardlindzon Posted - 1 month ago

Ketamine having a great week who makes It? I read $jnj and $tak would benefit (nno position)

MadTraderFlorida Posted - 1 month ago

$TAK

Stock_Titan Posted - 1 month ago

$TAK Takeda Announces U.S. FDA Approval of Supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) in Adult Patients with Newly Diagnosed Ph+ ALL https://www.stocktitan.net/news/TAK/takeda-announces-u-s-fda-approval-of-supplemental-new-drug-nmoddvr8ntet.html

Broview Posted - 1 month ago

$TAK earnings horrible seems barely or unable to cover dividend?

javarich Posted - 1 month ago

$LEAS $TAK $RHHBY $PFE I farted again

StonkGuyYezzir Posted - 1 month ago

$ENTX Given this $AZN acquisition, $ENTX looks VERY interesting here at 50M cap, has oral PTHR1 agonist in development for hypoparathyroidism, with early data comparable to $TAK Natpara. Stock up nicely YTD due to obesity hype and has preclinical GLP1/Glucagon oral agonist with $OPKO. News due sooner than later....

Quantumup Posted - 1 month ago

Jefferies⬆️ $MORF $60 was $45/Buy~says stock is getting >interesting@ a $1.8B MCAP as it gets closer2 Ph2B UC data in 1H25 (expects +VE data); thinks the bar isn't high4 a safe oral pill w/ a proven MoA /proven comm success ( $tak Entyvio FY23 $5.6B); says MORF attractive@ $1.8B.

javarich Posted - 1 month ago

@Winner4Ever then add a ticker $tak $PFIZER.NSE $leas $hmbl

briefingcom Posted - 1 month ago

$TAK: Takeda announces positive topline results from Phase 2 study evaluating Mezagitamab (TAK-079), a potential best-in-class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia

Stock_Titan Posted - 1 month ago

$TAK Takeda Announces Positive Topline Results from Phase 2 Study Evaluating Mezagitamab (TAK-079), a Potential Best-in-Class Anti-CD38 Monoclonal Antibody, for Primary Immune Thrombocytopenia https://www.stocktitan.net/news/TAK/takeda-announces-positive-topline-results-from-phase-2-study-9fwgydxm9h97.html

ElijahJobs Posted - 1 month ago

$TAK Any short-term catalyst for TAK, say till the end of April? I am getting tired of inaction... LOL

javarich Posted - 1 month ago

$LEAS $TAK 2 1/2 years and counting #3 officially

javarich Posted - 1 month ago

$LEAS not about first but who’s last for the record #3 and not bc of stockturds $TAK $HMBL First 10 likes get all expense paid trip to Scottsdale to meet Pete.

javarich Posted - 1 month ago

$leas $TAK more more more…pick me pick me I’m important Fart Excuse me Now what to do every post needs to go to $HMBL bc they suck balls and I was part of the worst dilution in history. More to be revealed here with this company when dust settles stop loss anyone. new$ Everymutherfucking pharma company in the world start with top $RHHBY Bye for now from mimanifesto PS stop worrying about day to day price action look at outstanding shares / volume that’s why it’s high when someone buys lunch or goes Tahoe for a vacation. You will want this when it’s fully converted $100 a share with a true valuation / market value.

javarich Posted - 1 month ago

$LEAS this is where I think we go $TAK I think when Moriarity founded Shire and got out after 2 years that there is unfinished business with $ANEW. These docs contribute to many boards both financial and medical. I believe this is there all in. Dr sinkhole is from Scottsdale moriarity lives in Scottsdale. Moriarty sold another company primo for 17 million when shire goes in the billions. He still made $$$ this is what seorrstes people with and those that don’t have $. It’s the all in factor, then it’s not a job but a passion and life work to fix the planet. and finally it’s living your best life. That’s the cycle. Dr sinkster lost his boy literally months ago and he’s bring a company from nothing to something. If you can’t get behind that, the team, the due diligence on mine yours and everyone’s behalf. I will hold until this is $TAK pharmaceutical. I think oh Peter boy might have $TAK on speed dial. Fart Excuse me Run with balls LFGOAT Fart Excuse me

Trend123 Posted - 1 month ago

$XBI $TAK $JAZZ $ZVRA $AQST almost doubled due to Q4 ER, after an already impressive run-up from their lows ( .7 $ to 5.6 ish ) but why ? « This 31% increase was primarily due to a one-time milestone royalty payment of $1 million for Azstarys from Zevra Therapeutics » « we saw a 104% increase in license and royalty revenue mostly due to the milestone licensing revenue for Azstarys from Zevra » So much coming, are you ready ? https://finance.yahoo.com/news/aquestive-therapeutics-inc-nasdaq-aqst-165607774.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNhLw&guce_referrer_sig=AQAAAKXvvMeiZn8Y-Qr2TT9qWGxNCyWIKjVvKT9awIgWm5TgM4Jrd6-IH7vbmjuih_PHI6qIFD8n3G5NkLUH7I3JSve_VwjTFCSXDHGD64IUwpbhjdvDTQ2Z2zUzEMZFvssxG0Nq8KMRBhaWv_7mbO9Nw8d7cHt3CqhmZEDF15w9lJ_n